ANXA2 was downregulated in adrenocortical carcinoma (ACC), KICH, acute myeloid leukemia (LAML), PRAD and skin cutaneous melanoma (SKCM) (Figure 1B). Here, ANXA2 is linked to cutaneous melanoma.